Article Versions Notes

Harris PE, Brasel T, Massey C, Herst CV, Burkholz S, Lloyd P, Blankenberg T, Bey TM, Carback R, Hodge T, et al. A Synthetic Peptide CTL Vaccine Targeting Nucleocapsid Confers Protection from SARS-CoV-2 Challenge in Rhesus Macaques. Vaccines. 2021; 9(5):520. https://doi.org/10.3390/vaccines9050520

Harris, Paul E., Trevor Brasel, Christopher Massey, C. V. Herst, Scott Burkholz, Peter Lloyd, Tikoes Blankenberg, Thomas M. Bey, Richard Carback, Thomas Hodge, and et al. 2021. "A Synthetic Peptide CTL Vaccine Targeting Nucleocapsid Confers Protection from SARS-CoV-2 Challenge in Rhesus Macaques" Vaccines 9, no. 5: 520. https://doi.org/10.3390/vaccines9050520

Harris, P. E., Brasel, T., Massey, C., Herst, C. V., Burkholz, S., Lloyd, P., Blankenberg, T., Bey, T. M., Carback, R., Hodge, T., Ciotlos, S., Wang, L., Comer, J. E., & Rubsamen, R. M. (2021). A Synthetic Peptide CTL Vaccine Targeting Nucleocapsid Confers Protection from SARS-CoV-2 Challenge in Rhesus Macaques. Vaccines, 9(5), 520. https://doi.org/10.3390/vaccines9050520